Bioterror in the Realm of Make-Believe

Can the United States cope with biological terrorism? The anthrax deaths have invested this question with new urgency, eliciting many opinions at the Pentagon and in Washington's think tanks. But the dubious benefit of prior experience on which to base those opinions is scarce. One way to get the experience is by the technological play-acting known as simulation. The US Army has used virtual reality simulations for combat training since the late 1980s. Trainees are placed inside a module, three

Written bySteve Bunk
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

The US Army has used virtual reality simulations for combat training since the late 1980s. Trainees are placed inside a module, three or four walls of which are filled with computer-generated screens of a battlefield terrain seen from different perspectives. Participants might be inside a replicated combat vehicle or walking a treadmill through a virtual cave. They wear electronic devices that monitor their movements as they encounter those designated as the enemy, who are operating other modules. Everyone is networked by simulated radio communications to battalion and brigade command posts. The military calls this "sweaty palms realism," because the soldiers react as though they're in a real battle, despite the knowledge that it's virtual. The numbers of such training stations initially were limited, but computer-based simulators now allow widespread access. Why couldn't this technology be adapted to drill health workers on the possibilities of a bioterrorist attack?

It can be, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies